George A. Samuel III - 01 Sep 2021 Form 4 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role
General Counsel/Secretary
Signature
/s/ Grant Harbert, as Attorney-in-Fact
Issuer symbol
LCTX
Transactions as of
01 Sep 2021
Transactions value $
$0
Form type
4
Filing time
02 Sep 2021, 16:20:32 UTC
Next filing
15 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LCTX Employee Stock Option (right to buy) Award $0 +695K $0.00 695K 01 Sep 2021 Common Shares 695K $2.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest as to one quarter of the shares subject to the option on September 1, 2022, and the balance will vest in 36 successive substantially equal monthly installments thereafter, subject to the reporting person's continuous employment.